2 years ago
VKTX
AnalystsRoger SongRoger Song's Stock Forecasts
AnalystsRoger Song
Analyst Ranking
Top 24%
#1179 out of 5087 analysts
Average Return
+8.76%
Win Rate
43%20 out of 47
Risk vs Reward
Poor
Good
Roger Song's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nektar TherapeuticsNKTR | +600.81% | $9.27 | $64.93 | 2025-04-11 - 2025-10-31 | Strong Buy |
Replimune Group IncREPL | +246.88% | $2.81 | $9.73 | 2025-07-22 - 2025-10-31 | Strong Buy |
Atyr Pharma IncATYR | +212.57% | $1.75 | $5.47 | 2024-09-05 - 2025-09-04 | Strong Buy |
Sutro Biopharma IncSTRO | +92.81% | $11.27 | $21.72 | 2020-09-02 - 2021-08-31 | Strong Buy |
Disc Medicine IncIRON | +85.61% | $46.99 | $87.22 | 2024-10-23 - 2025-10-22 | Strong Buy |
Roger Song Analyst Color
Get additional color on Roger Song's coverage of popular stocks
Roger Song's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gyre Therapeutics IncGYRE | 1 | Strong Buy | $16.00 | +106.45% | Initiates Coverage On | 24 days ago |
Tourmaline Bio IncTRML | 3 | Hold | $47.50 | -1.00% | Downgrades | 2 months ago |
United Therapeutics CorpUTHR | 1 | Strong Buy | $564.00 | +26.62% | Maintains | 2 months ago |
Biomea Fusion IncBMEA | 1 | Strong Buy | $5.00 | +267.65% | Initiates Coverage On | 2 months ago |
Atyr Pharma IncATYR | 2 | Strong Buy | $17.00 | +1,863.05% | Maintains | 2 months ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $36.00 | +63.93% | Assumes | 3 months ago |
Lava Therapeutics NvLVTX | 1 | Hold | $1.50 | -7.69% | Downgrades | 3 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 3 | Strong Buy | $54.00 | +45.91% | Maintains | 3 months ago |
Replimune Group IncREPL | 2 | Strong Buy | $6.00 | -38.34% | Maintains | 3 months ago |
Verve Therapeutics IncVERV | 1 | Hold | $11.00 | -1.17% | Downgrades | 5 months ago |
Curevac NvCVAC | 1 | Hold | $5.00 | -6.37% | Downgrades | 5 months ago |
Nektar TherapeuticsNKTR | 10 | Strong Buy | $30.00 | -53.80% | Upgrades | 7 months ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $6.00 | +171.49% | Initiates Coverage On | 7 months ago |
Sana Biotechnology IncSANA | 1 | Strong Buy | $7.00 | +41.41% | Initiates Coverage On | 8 months ago |
Krystal Biotech IncKRYS | 1 | Strong Buy | $245.00 | +24.04% | Initiates Coverage On | 8 months ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $26.00 | +187.61% | Initiates Coverage On | 8 months ago |
Igm Biosciences IncIGMS | 2 | Hold | $2.00 | +57.48% | Downgrades | 10 months ago |
Bioage Labs IncBIOA | 2 | Hold | $7.00 | -7.53% | Downgrades | a year ago |
Kura Oncology IncKURA | 2 | Strong Buy | $28.00 | +172.64% | Maintains | a year ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $7.00 | +177.78% | Upgrades | a year ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | N/A | Initiates Coverage On | a year ago |
Novavax IncNVAX | 2 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | a year ago |
Zenas Biopharma IncZBIO | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Vaxcyte IncPCVX | 1 | Strong Buy | $129.00 | N/A | Maintains | a year ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Buy | $8.00 | N/A | Upgrades | a year ago |
Nuvalent IncNUVL | 1 | Strong Buy | $97.00 | N/A | Initiates Coverage On | 2 years ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 2 years ago |
Kinnate Biopharma IncKNTE | 2 | Strong Buy | $2.00 | N/A | Maintains | 2 years ago |
Altimmune IncALT | 1 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Prelude Therapeutics IncPRLD | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Whitehawk Therapeutics IncWHWK | 1 | Strong Buy | $675.00 | N/A | Initiates Coverage On | 4 years ago |
Corvus Pharmaceuticals IncCRVS | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 4 years ago |
Crescent Biopharma IncCBIO | 1 | Strong Buy | $4.00 | N/A | Upgrades | 4 years ago |
Atreca IncBCEL | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Molecular Templates IncMTEM | 1 | Strong Buy | $315.00 | N/A | Initiates Coverage On | 5 years ago |
Sutro Biopharma IncSTRO | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.